SG Americas Securities’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,493
| Closed | -$388K | – | 3112 |
|
|
2024
Q4 | $388K | Buy |
+24,493
| New | +$388K | ﹤0.01% | 1376 |
|
|
2024
Q3 | – | Sell |
-11,633
| Closed | -$532K | – | 3056 |
|
|
2024
Q2 | $532K | Buy |
+11,633
| New | +$532K | ﹤0.01% | 1502 |
|
|
2024
Q1 | – | Sell |
-12,252
| Closed | -$487K | – | 2798 |
|
|
2023
Q4 | $487K | Sell |
12,252
-34,931
| -74% | -$1.39M | ﹤0.01% | 1350 |
|
|
2023
Q3 | $1.5M | Buy |
47,183
+38,857
| +467% | +$1.24M | 0.02% | 870 |
|
|
2023
Q2 | $335K | Sell |
8,326
-19,728
| -70% | -$794K | ﹤0.01% | 1371 |
|
|
2023
Q1 | $1.2M | Buy |
28,054
+13,949
| +99% | +$596K | 0.01% | 925 |
|
|
2022
Q4 | $677K | Buy |
14,105
+6,079
| +76% | +$292K | 0.01% | 1130 |
|
|
2022
Q3 | $302K | Sell |
8,026
-4,771
| -37% | -$180K | ﹤0.01% | 1770 |
|
|
2022
Q2 | $354K | Buy |
12,797
+9,853
| +335% | +$273K | ﹤0.01% | 2051 |
|
|
2022
Q1 | $160K | Buy |
2,944
+243
| +9% | +$13.2K | ﹤0.01% | 2266 |
|
|
2021
Q4 | $158K | Sell |
2,701
-4,582
| -63% | -$268K | ﹤0.01% | 2519 |
|
|
2021
Q3 | $288K | Buy |
+7,283
| New | +$288K | ﹤0.01% | 2737 |
|
|
2021
Q2 | – | Sell |
-2,725
| Closed | -$168K | – | 2693 |
|
|
2021
Q1 | $168K | Buy |
+2,725
| New | +$168K | ﹤0.01% | 2543 |
|
|
2020
Q3 | – | Sell |
-4,087
| Closed | -$153K | – | 2546 |
|
|
2020
Q2 | $153K | Buy |
+4,087
| New | +$153K | ﹤0.01% | 2668 |
|